Reporting Manager
Poplar Point Capital Management LLC
Symbol
NBY
Shares outstanding
5,823,630 shares
Disclosed Ownership
1,020,300 shares
Ownership
18%
Form type
SCHEDULE 13D/A
Filing time
17 Oct 2025, 17:10:52 UTC
Date of event
15 Oct 2025
Previous filing
04 Sep 2025
Next filing
11 Mar 2026

Sponsored

Quoteable Key Fact

"POPLAR POINT CAPITAL MANAGEMENT LLC disclosed 18% ownership in Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY) on 15 Oct 2025."

Quick Takeaways

  • POPLAR POINT CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Novabay Pharmaceuticals, Inc. Common Stock, par value $0.01 per share (NBY).
  • Disclosed ownership: 18%.
  • Date of event: 15 Oct 2025.

What Changed

  • Previous schedule filing date: 04 Sep 2025.
  • Current filing was accepted on 17 Oct 2025, 17:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Poplar Point Capital Management LLC 18% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588273
Poplar Point Capital Partners LP 18% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588289
Poplar Point Capital GP LLC 18% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry, Manager 0001588288
Jad Fakhry 18% 1,020,300 0 1,020,300 /s/ Jad Fakry Jad Fakhry 0001588217